Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS

Table of Contents

October 01, 2005; Volume 32,Issue 10
  • You have access
    Preventing deaths from methotrexate overdose.
    Edward Etchells
    The Journal of Rheumatology October 1 2005, 32 (10) 1853-1855;
  • You have access
    Use of low-dose glucocorticoids and the risk of cardiovascular morbidity and mortality in rheumatoid arthritis: what is the true direction of effect?
    John M Davis 3rd, Hilal Maradit-Kremers and Sherine E Gabriel
    The Journal of Rheumatology October 1 2005, 32 (10) 1856-1862;
  • You have access
    Steroids for rheumatoid arthritis: the honeymoon revisited (once again).
    Liron Caplan, Anthony S Russell and Frederick Wolfe
    The Journal of Rheumatology October 1 2005, 32 (10) 1863-1865;
  • You have access
    Malignancy and rheumatic disease--a real association?
    Sharon Chambers and David Isenberg
    The Journal of Rheumatology October 1 2005, 32 (10) 1866-1867;
  • You have access
    Bone mineral content versus bone density in a population with osteoarthritis: a new twist to the controversy?
    M Heather McDonald Blumer
    The Journal of Rheumatology October 1 2005, 32 (10) 1868-1869;
  • You have access
    ADAM proteins as therapeutic targets in loosening of total hip replacement implants?
    Silvia Naus and Jörg Walter Bartsch
    The Journal of Rheumatology October 1 2005, 32 (10) 1870-1872;
  • You have access
    Race, scleroderma, and survival: why is there a difference?
    Maureen D Mayes
    The Journal of Rheumatology October 1 2005, 32 (10) 1873-1874;
  • You have access
    Household income and earnings losses among 6,396 persons with rheumatoid arthritis.
    Frederick Wolfe, Kaleb Michaud, Hyon K Choi and Rhys Williams
    The Journal of Rheumatology October 1 2005, 32 (10) 1875-1883;
  • You have access
    Autoimmune disease is a risk factor for the development of non-Hodgkin's lymphoma.
    Janet Cuttner, Harry Spiera, Kevin Troy and Sylvan Wallenstein
    The Journal of Rheumatology October 1 2005, 32 (10) 1884-1887;
  • You have access
    Demographic and clinical factors associated with in-hospital death among patients with systemic sclerosis.
    Paul J Nietert, Richard M Silver, Holly C Mitchell, Stephanie R Shaftman and Barbara C Tilley
    The Journal of Rheumatology October 1 2005, 32 (10) 1888-1892;
  • You have access
    Distinct expression of adhesion molecules on skin fibroblasts from patients with diffuse and limited systemic sclerosis. A pilot study.
    Florenzo Iannone, Marco Matucci-Cerinic, Paola Chiara Francesca Falappone, Serena Guiducci, Marina Cinelli, Oliver Distler and Giovanni Lapadula
    The Journal of Rheumatology October 1 2005, 32 (10) 1893-1898;
  • You have access
    The Cochrane review of physiotherapy interventions for ankylosing spondylitis.
    Hanne Dagfinrud, Tore K Kvien and Kåre B Hagen
    The Journal of Rheumatology October 1 2005, 32 (10) 1899-1906;
  • You have access
    Interleukin 1 and nuclear factor-kappaB polymorphisms in ankylosing spondylitis in Canada and Korea.
    Tae-Hwan Kim, Millicent A Stone, Proton Rahman, Dae-Hyun Yoo, Yong-Wook Park, Ursula Payne, Dave Hallett and Robert D Inman
    The Journal of Rheumatology October 1 2005, 32 (10) 1907-1910;
  • You have access
    Etanercept exerts beneficial effects on articular cartilage biomarkers of degradation and turnover in patients with ankylosing spondylitis.
    Walter P Maksymowych, A Robin Poole, Lori Hiebert, Alison Webb, Mirela Ionescu, Tatiana Lobanok, Lindsay King and John C Davis Jr
    The Journal of Rheumatology October 1 2005, 32 (10) 1911-1917;
  • You have access
    Prevalence, disease manifestations, and treatment of psoriatic arthritis in Western Norway.
    Tor Magne Madland, Ellen M Apalset, Arild E Johannessen, Berthe Rossebö and Johan G Brun
    The Journal of Rheumatology October 1 2005, 32 (10) 1918-1922;
  • You have access
    Factors associated with musculoskeletal disability and chronic renal failure in clinically diagnosed primary gout.
    José Alvarez-Nemegyei, Julio Cesar Cen-Pisté, Martha Medina-Escobedo and Salha Villanueva-Jorge
    The Journal of Rheumatology October 1 2005, 32 (10) 1923-1927;
  • You have access
    Clinical effects of intraarticular injection of high molecular weight hyaluronan (Orthovisc) in osteoarthritis of the knee: a randomized, controlled, multicenter trial.
    David Neustadt, Jacques Caldwell, Mary Bell, John Wade and Joseph Gimbel
    The Journal of Rheumatology October 1 2005, 32 (10) 1928-1936;
  • You have access
    The genetic contribution and relevance of knee cartilage defects: case-control and sib-pair studies.
    Changhai Ding, Flavia Cicuttini, Fiona Scott, James Stankovich, Helen Cooley and Graeme Jones
    The Journal of Rheumatology October 1 2005, 32 (10) 1937-1942;
  • You have access
    Increased expression and processing of ADAM 12 (meltrin-alpha) in osteolysis associated with aseptic loosening of total hip replacement implants.
    Guofeng Ma, Mari Ainola, Mikko Liljeström, Seppo Santavirta, Praseet Poduval, Desheng Zhao, Tong Chen and Yrjö T Konttinen
    The Journal of Rheumatology October 1 2005, 32 (10) 1943-1950;
  • You have access
    Increased bone mineral content but not bone mineral density in the hip in surgically treated knee and hip osteoarthritis.
    Lorenzo Sandini, Jari P A Arokoski, Jukka S Jurvelin and Heikki Kröger
    The Journal of Rheumatology October 1 2005, 32 (10) 1951-1957;
  • You have access
    Comparative effects of 2 antioxidants, selenomethionine and epigallocatechin-gallate, on catabolic and anabolic gene expression of articular chondrocytes.
    Rina Andriamanalijaona, Madeleine Kypriotou, Catherine Baugé, Emmanuelle Renard, Florence Legendre, Maha Raoudi, Karim Boumediene, Hugues Gatto, Patricia Monginoux and Jean-Pierre Pujol
    The Journal of Rheumatology October 1 2005, 32 (10) 1958-1967;
  • You have access
    Safety and tolerability of oral daily and intermittent ibandronate are not influenced by age.
    Mark P Ettinger, Dieter Felsenberg, Steven T Harris, Richard Wasnich, Arne Skag, Valerie Hiltbrunner, Katie Wilson, Ralph C Schimmer and Paul D Miller
    The Journal of Rheumatology October 1 2005, 32 (10) 1968-1974;
  • You have access
    Efficacy of milnacipran in patients with fibromyalgia.
    R Michael Gendreau, Michael D Thorn, Judy F Gendreau, Jay D Kranzler, Saulo Ribeiro, Richard H Gracely, David A Williams, Philip J Mease, Samuel A McLean and Daniel J Clauw
    The Journal of Rheumatology October 1 2005, 32 (10) 1975-1985;
  • You have access
    Eye findings in patients with juvenile dermatomyositis.
    Jonathan D Akikusa, Dhenuka K Tennankore, Alex V Levin and Brian M Feldman
    The Journal of Rheumatology October 1 2005, 32 (10) 1986-1991;
  • You have access
    Longitudinal analysis of a pediatric rheumatology clinic population.
    Alan M Rosenberg
    The Journal of Rheumatology October 1 2005, 32 (10) 1992-2001;
  • You have access
    Poststreptococcal reactive arthritis with thoracic spine involvement in an adult.
    Alexandra Alexopoulou, Spyros P Dourakis, Nikolaos D Stamoulis, Dimitrios Vassilopoulos and Athanasios J Archimandritis
    The Journal of Rheumatology October 1 2005, 32 (10) 2002-2005;
  • You have access
    Synovial sarcoma of the foot mimicking acute gouty arthritis.
    Ying Du, Sally Pullman-Mooar and H Ralph Schumacher
    The Journal of Rheumatology October 1 2005, 32 (10) 2006-2008;
  • You have access
    Deaths following methotrexate overdoses by medical staff.
    Inga Sinicina, Barbara Mayr, Gita Mall and Wolfgang Keil
    The Journal of Rheumatology October 1 2005, 32 (10) 2009-2011;
  • You have access
    Minimal disease activity for rheumatoid arthritis: a preliminary definition.
    George A Wells, Maarten Boers, Beverley Shea, Peter M Brooks, Lee S Simon, C Vibeke Strand, Daniel Aletaha, Jennifer J Anderson, Claire Bombardier, Maxime Dougados, Paul Emery, David T Felson, Jaap Fransen, Dan E Furst, Johanna M W Hazes, Kent R Johnson, John R Kirwan, Robert B M Landewé, Marissa N D Lassere, Kaleb Michaud, Maria Suarez-Almazor, Alan J Silman, Josef S Smolen, Desiree M F M Van der Heijde, Piet L C M van Riel, Fred Wolfe and Peter S Tugwell
    The Journal of Rheumatology October 1 2005, 32 (10) 2016-2024;
  • You have access
    Minimal clinically important difference, low disease activity state, and patient acceptable symptom state: methodological issues.
    Florence Tubach, George A Wells, Philippe Ravaud and Maxime Dougados
    The Journal of Rheumatology October 1 2005, 32 (10) 2025-2029;
  • You have access
    Challenges and progress in adverse event ascertainment and reporting in clinical trials.
    Marissa N D Lassere, Kent R Johnson, Thasia G Woodworth, Daniel E Furst, James F Fries, John R Kirwan, Peter S Tugwell, Richard O Day and Peter M Brooks
    The Journal of Rheumatology October 1 2005, 32 (10) 2030-2032;
  • You have access
    Generic patient self-report and investigator report instruments of therapeutic safety and tolerability.
    Marissa N D Lassere, Kent R Johnson, Susanne Van Santen, Kerri Carlton, Joy Rappo, Rachel Michael, John R Kirwan and John P Edmonds
    The Journal of Rheumatology October 1 2005, 32 (10) 2033-2036;
  • You have access
    Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module update.
    Marissa N D Lassere, Kent R Johnson, Maarten Boers, Kerri Carlton, Richard O Day, Marten de Wit, I Ralph Edwards, James F Fries, Daniel E Furst, John R Kirwan, Peter S Tugwell, Thasia G Woodworth and Peter M Brooks
    The Journal of Rheumatology October 1 2005, 32 (10) 2037-2041;
  • You have access
    Application of the OMERACT filter to scoring methods for magnetic resonance imaging of the sacroiliac joints and the spine. Recommendations for a research agenda at OMERACT 7.
    Désirée M F M van der Heijde, Robert B M Landewé, Kay-Geert A Hermann, Anne-Grethe Jurik, Walter P Maksymowych, Martin Rudwaleit, Philip J O'Connor and Jürgen Braun
    The Journal of Rheumatology October 1 2005, 32 (10) 2042-2047;
  • You have access
    Selection of a method for scoring radiographs for ankylosing spondylitis clinical trials, by the Assessment in Ankylosing Spondylitis Working Group and OMERACT.
    Désirée van der Heijde and Robert Landewé
    The Journal of Rheumatology October 1 2005, 32 (10) 2048-2049;
  • You have access
    Scoring sacroiliac joints by magnetic resonance imaging. A multiple-reader reliability experiment.
    Robert B M LandewÉ, Kay-Geert A Hermann, DÉsirÉÉe M F M van der Heijde, Xenophon Baraliakos, Anne-Grethe Jurik, Robert G Lambert, Mikkel Østergaard, Martin Rudwaleit, David C Salonen and JÜrgen Braun
    The Journal of Rheumatology October 1 2005, 32 (10) 2050-2055;
  • You have access
    Magnetic resonance imaging of inflammatory lesions in the spine in ankylosing spondylitis clinical trials: is paramagnetic contrast medium necessary?
    Kay-Geert A Hermann, Robert B M Landewé, Jürgen Braun and Désirée M F M van der Heijde
    The Journal of Rheumatology October 1 2005, 32 (10) 2056-2060;
  • You have access
    Treating leukocytoclastic vasculitis associated with etanercept therapy. Is it necessary to stop etanercept?
    Antonio Juan, Bartolome Ribas, Cristina Nadal and Imnaculada Ros
    The Journal of Rheumatology October 1 2005, 32 (10) 2061;
  • You have access
    CTLA-4 -1661A/G and -1772T/C dimorphisms in Japanese patients with systemic lupus erythematosus.
    Fujio Takeuchi, Shoji Kuwata and Masaki Mori
    The Journal of Rheumatology October 1 2005, 32 (10) 2062;
Back to top
PreviousNext

In this issue

The Journal of Rheumatology
Vol. 32, Issue 10
1 Oct 2005
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Most Read
  • ​ Editor's Picks
  • E-letters
Loading
  • Effects of Bedtime Very Low Dose Cyclobenzaprine on Symptoms and Sleep Physiology in Patients with Fibromyalgia Syndrome: A Double-blind Randomized Placebo-controlled Study
  • Extravascular Necrotizing Granuloma: A Diagnostic Clue for Eosinophilic Granulomatosis With Polyangiitis
  • Immunoglobulin A Vasculitis Following COVID-19: A French Multicenter Case Series
  • Immune Response to SARS-CoV-2 Third Vaccine in Patients With Rheumatoid Arthritis Who Had No Seroconversion After Primary 2-Dose Regimen With Inactivated or Vector-Based Vaccines
  • Melorheostosis or “Dripping Candle Wax” Bone Disease
More...

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire